Sammenlignet med de farmakokinetiske data fra voksne med kronisk nyresvigt id
who were either receiving or not receiving dialysis determined pharmacokinetic profiles for sampling periods up to 1 week (168 hours) after a single subcutaneous or intravenous dose.